Acadia Healthcare (NASDAQ:ACHC) received a $42.00 price objective from equities research analysts at Jefferies Group in a research note issued on Tuesday, December 19th. The brokerage currently has a “buy” rating on the stock. Jefferies Group’s price objective points to a potential upside of 21.28% from the company’s current price. Jefferies Group also issued estimates for Acadia Healthcare’s Q1 2018 earnings at $0.47 EPS, Q2 2018 earnings at $0.66 EPS, Q3 2018 earnings at $0.64 EPS and FY2018 earnings at $2.40 EPS.
ACHC has been the subject of several other reports. BMO Capital Markets initiated coverage on shares of Acadia Healthcare in a research report on Monday, October 16th. They issued an “outperform” rating and a $52.00 price objective for the company. KeyCorp reaffirmed a “buy” rating and issued a $59.00 price target on shares of Acadia Healthcare in a research report on Friday, October 20th. Mizuho set a $60.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, October 12th. Finally, Citigroup lowered their price target on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $44.17.
Acadia Healthcare (NASDAQ:ACHC) traded up $0.25 during trading on Tuesday, reaching $34.63. 871,402 shares of the company’s stock traded hands, compared to its average volume of 1,157,118. The stock has a market cap of $3,020.41, a PE ratio of 17.58, a price-to-earnings-growth ratio of 1.17 and a beta of 0.90. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million during the quarter, compared to analysts’ expectations of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. Acadia Healthcare’s quarterly revenue was down 2.4% on a year-over-year basis. During the same period last year, the firm earned $0.58 earnings per share. research analysts predict that Acadia Healthcare will post 2.23 earnings per share for the current year.
In related news, Director Reeve B. Waud sold 100,000 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.
A number of large investors have recently bought and sold shares of ACHC. State Street Corp increased its stake in Acadia Healthcare by 95.2% during the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock valued at $98,667,000 after purchasing an additional 974,524 shares in the last quarter. Royal Bank of Canada increased its stake in Acadia Healthcare by 25.0% during the 2nd quarter. Royal Bank of Canada now owns 19,306 shares of the company’s stock valued at $954,000 after purchasing an additional 3,856 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in Acadia Healthcare by 2,358.9% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock valued at $1,424,000 after purchasing an additional 27,670 shares in the last quarter. Nationwide Fund Advisors increased its stake in Acadia Healthcare by 5.2% during the 3rd quarter. Nationwide Fund Advisors now owns 259,773 shares of the company’s stock valued at $12,407,000 after purchasing an additional 12,931 shares in the last quarter. Finally, Mutual of America Capital Management LLC increased its stake in Acadia Healthcare by 47.8% during the 2nd quarter. Mutual of America Capital Management LLC now owns 409,179 shares of the company’s stock valued at $20,205,000 after purchasing an additional 132,356 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: “Acadia Healthcare (ACHC) PT Set at $42.00 by Jefferies Group” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/14/jefferies-group-analysts-give-acadia-healthcare-achc-a-42-00-price-target.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.